[HTML][HTML] Incidence, survival, and mortality trends of cancers diagnosed in adolescents and young adults (15–39 years): a population-based study in The Netherlands …

DJ van Der Meer, HE Karim-Kos, M van Der Mark… - Cancers, 2020 - mdpi.com
Simple Summary Adolescents and young adults (AYAs, aged 15–39 years) with cancer form
a distinct patient population within the oncology care setting that is often overlooked in …

[PDF][PDF] Incidence, Survival, and Mortality Trends of Cancers Diagnosed in Adolescents and Young Adults (15–39 Years): A Population-Based Study in The Netherlands …

DJ van der Meer, HE Karim-Kos, M van der Mark… - pdfs.semanticscholar.org
Adolescent and young adult (AYA) cancer patients, aged 15–39 years at primary cancer
diagnosis, form a distinct, understudied, and underserved group in cancer care. This study …

[PDF][PDF] Incidence, Survival, and Mortality Trends of Cancers Diagnosed in Adolescents and Young Adults (15–39 Years): A Population-Based Study in The Netherlands …

DJ van der Meer, HE Karim-Kos, M van der Mark… - researchinformation.umcutrecht.nl
Adolescent and young adult (AYA) cancer patients, aged 15–39 years at primary cancer
diagnosis, form a distinct, understudied, and underserved group in cancer care. This study …

Incidence, Survival, and Mortality Trends of Cancers Diagnosed in Adolescents and Young Adults (15–39 Years): A Population-Based Study in The Netherlands 1990 …

DJ van der Meer, HE Karim-Kos, M van der Mark… - search.proquest.com
Adolescent and young adult (AYA) cancer patients, aged 15–39 years at primary cancer
diagnosis, form a distinct, understudied, and underserved group in cancer care. This study …

Incidence, survival, and mortality trends of cancers diagnosed in adolescents and young adults (15–39 years): A population-based study in The Netherlands 1990 …

DJ van der Meer, HE Karim-Kos, M van der Mark… - Cancers, 2020 - repub.eur.nl
Adolescent and young adult (AYA) cancer patients, aged 15–39 years at primary cancer
diagnosis, form a distinct, understudied, and underserved group in cancer care. This study …

Incidence, Survival, and Mortality Trends of Cancers Diagnosed in Adolescents and Young Adults (15-39 Years): A Population-Based Study in The Netherlands 1990 …

DJ van der Meer, HE Karim-Kos, M van der Mark… - Cancers, 2020 - europepmc.org
Adolescent and young adult (AYA) cancer patients, aged 15–39 years at primary cancer
diagnosis, form a distinct, understudied, and underserved group in cancer care. This study …

[PDF][PDF] Incidence, Survival, and Mortality Trends of Cancers Diagnosed in Adolescents and Young Adults (15-39 Years): A Population-Based Study in The Netherlands …

DJ Meer, HE Karim-Kos, M Mark, KKH Aben… - 2020 - repository.ubn.ru.nl
Adolescent and young adult (AYA) cancer patients, aged 15–39 years at primary cancer
diagnosis, form a distinct, understudied, and underserved group in cancer care. This study …

Incidence, survival, and mortality trends of cancers diagnosed in adolescents and young adults (15-39 years): a population-based study in the Netherlands 1990-2016 …

DJ van Der Meer, HE Karim-Kos, M van Der Mark… - 2020 - cabidigitallibrary.org
Adolescent and young adult (AYA) cancer patients, aged 15-39 years at primary cancer
diagnosis, form a distinct, understudied, and underserved group in cancer care. This study …

Incidence, Survival, and Mortality Trends of Cancers Diagnosed in Adolescents and Young Adults (15-39 Years): A Population-Based Study in The Netherlands 1990 …

DJ van der Meer, HE Karim-Kos… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Adolescent and young adult (AYA) cancer patients, aged 15-39 years at primary cancer
diagnosis, form a distinct, understudied, and underserved group in cancer care. This study …

Incidence, Survival, and Mortality Trends of Cancers Diagnosed in Adolescents and Young Adults (15-39 Years): A Population-Based Study in The Netherlands 1990 …

DJ van der Meer, HE Karim-Kos, M van der Mark… - Cancers, 2020 - go.gale.com
Adolescents and young adults (AYAs, aged 15-39 years) with cancer form a distinct patient
population within the oncology care setting that is often overlooked in favour of paediatric …